Cancer cure is almost at hand, as some scientists claimed that they finally discovered how to treat the dreaded illness. People have been waiting for the cure for decades as the chances of survival is slim, especially because treatments are expensive, and there is no exact method to treat certain types of the disease.
Now, it was said that a team of scientists at Cardiff University discovered a way to kill the cancerous cells in breasts, prostate, lungs, and other parts of the body. They made the discovery after finding part of the immune system that can be used for treating all types of cancers.
The research findings
In the study that was published in Nature Immunology, it was stated that they found the T cell, and it can be a cure because it targets “cancer cells would allow immune destruction of malignancies in all individuals.”
Then again, the experts said that they have yet to test it on actual cancer patients. Although this is still untested and in an early stage, they think that this treatment has an enormous potential to be effective.
The T-cell was found because the scientists are researching on how the immune system could naturally attack the cancerous tumors and give the human body its natural defense mechanism against infection and cancer cells. The T-cell was located in the blood, and since this is the case, it can be a cure to all forms of cancers.
"There's a chance here to treat every patient," researcher Prof Andrew Sewell told BBC News. "Previously nobody believed this could be possible. It raises the prospect of a 'one-size-fits-all' cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population."
How this cure is supposed to work
Based on the report, the T-cell has receptors that let them spot any anomalies at a chemical level. Due to this ability, it can find and eliminate an array of cancerous tumors that can develop in the kidney, blood, skin, bone, breast, ovaries, prostate, and more. And while it will attack cancer or any bad cells, it will leave the normal tissues alone.
Finally, the doctors stated that this has not been done before, but the T-cell can be a universal cancer treatment later on if they will succeed in applying it to patients afflicted with Big C.


Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 



